Epstein–Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma

Clinical and Translational Oncology

Volumn 18, Issue 2, 2016, Pages 206-211

  Zeng, Z ^a   Fan, S ^b   Zhang, X ^a   Li, S ^a   Zhou, M ^a   Xiong, W ^a   Tan, M ^a,c   Zhang, W ^a   Li, G ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

EBV encoded small RNA 1 (EBER 1); Epstein Barr virus (EBV); Nasopharyngeal carcinoma (NPC); Prognosis

Indexed keywords

EPSTEIN BARR VIRUS ENCODED SMALL RNA 1; UNCLASSIFIED DRUG; UNTRANSLATED RNA; EPSTEIN-BARR VIRUS ENCODED RNA 1; TUMOR MARKER; VIRUS RNA;

AREA UNDER THE CURVE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; TUMOR VOLUME; UPREGULATION; BIOSYNTHESIS; COMPLICATION; EPSTEIN BARR VIRUS INFECTION; KAPLAN MEIER METHOD; MORTALITY; NASOPHARYNX TUMOR; PATHOLOGY; PROGNOSIS; VIROLOGY;

AREA UNDER CURVE; BIOMARKERS, TUMOR; DISEASE-FREE SURVIVAL; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; IN SITU HYBRIDIZATION; KAPLAN-MEIER ESTIMATE; NASOPHARYNGEAL NEOPLASMS; PROGNOSIS; RNA, VIRAL; ROC CURVE; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS; UP-REGULATION;

EID: 84955723585     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-015-1354-3     Document Type: Article

References (38)

1. Ahmed W, Khan G. The labyrinth of interactions of Epstein–Barr virus-encoded small RNAs. Rev Med Virol. 2013;24(1):3–14. doi:10.1002/rmv.1763.
2. Zeng Z, Zhou Y, Zhang W, Li X, Xiong W, Liu H, et al. Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med. 2006;8(3):156–60. doi:10.1097/01.gim.0000196821.87655.d0.
3. Xiong W, Zeng ZY, Xia JH, Xia K, Shen SR, Li XL, et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res. 2004;64(6):1972–4.
4. Zeng Z, Huang H, Zhang W, Xiang B, Zhou M, Zhou Y, et al. Nasopharyngeal carcinoma: advances in genomics and molecular genetics. Sci China Life Sci. 2011;54(10):966–75. doi:10.1007/s11427-011-4223-5.
5. Takada K. Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis. Semin Cancer Biol. 2012;22(2):162–5. doi:10.1016/j.semcancer.2011.12.007.
6. Raab-Traub N. Epstein–Barr virus in the pathogenesis of NPC. Semin Cancer Biol. 2002;12(6):431–41.
7. Liao Q, Zeng Z, Guo X, Li X, Wei F, Zhang W, et al. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene. 2014;33(16):2098–109. doi:10.1038/onc.2013.161.
8. Yang Y, Liao Q, Wei F, Li X, Zhang W, Fan S, et al. LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways. PLoS One. 2013;8(5):e62869. doi: 10.1371/journal.pone.0062869
9. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s Lymphoma. Lancet. 1964;1(7335):702–3.
10. Yu Z, Song Y, Gong Z, Zeng Z, Lu J, Li X, et al. The mechanism and tumorigenesis of oncogenic DNA virus integration. Prog Biochem Biophys. 2014;41(4):324–31. doi:10.3724/SP.J.1206.2012.00554.
11. Young LS, Rickinson AB. Epstein–Barr virus: 40 years on. Nat Rev Cancer. 2004;4(10):757–68. doi:10.1038/nrc1452.
12. Zhou Y, Zeng Z, Zhang W, Xiong W, Wu M, Tan Y, et al. Lactotransferrin: a candidate tumor suppressor-deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int J cancer. 2008;123(9):2065–72. doi:10.1002/ijc.23727.
13. Henle G, Henle W. Epstein–Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J cancer. 1976;17(1):1–7.
14. Wang Y, Zhang X, Chao Y, Jia Y, Xing X, Luo B. New variations of Epstein–Barr virus-encoded small RNA genes in nasopharyngeal carcinomas, gastric carcinomas, and healthy donors in northern China. J Med Virol. 2010;82(5):829–36. doi:10.1002/jmv.21714.
15. Fan SQ, Ma J, Zhou J, Xiong W, Xiao BY, Zhang WL, et al. Differential expression of Epstein–Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Hum Pathol. 2006;37(5):593–605. doi:10.1016/j.humpath.2006.01.010
16. Zhang W, Zeng Z, Zhou Y, Xiong W, Fan S, Xiao L, et al. Identification of aberrant cell cycle regulation in Epstein–Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis. Acta Biochim et Biophys Sin. 2009;41(5):414–28.
17. Xiong W, Wu X, Starnes S, Johnson SK, Haessler J, Wang S, et al. An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma. Blood. 2008;112(10):4235–46. doi:10.1182/blood-2007-10-119123.
18. Zeng ZY, Zhou YH, Zhang WL, Xiong W, Fan SQ, Li XL, et al. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol. 2007;38(1):120–33. doi:10.1016/j.humpath.2006.06.023.
19. Zeng Z, Zhou Y, Xiong W, Luo X, Zhang W, Li X, et al. Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray. J Cancer Res Clin Oncol. 2007;133(2):71–81. doi:10.1007/s00432-006-0136-2.
20. Zhou Y, Zeng Z, Zhang W, Xiong W, Li X, Zhang B, et al. Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization. Eur J Cancer Prev. 2008;17(6):561–71. doi:10.1097/CEJ.0b013e328305a0e8.
21. Brooks L, Yao QY, Rickinson AB, Young LS. Epstein–Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol. 1992;66(5):2689–97.
22. Zeng Z, Huang H, Huang L, Sun M, Yan Q, Song Y, et al. Regulation network and expression profiles of Epstein–Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas. Sci China Life Sci. 2014;57(3):315–26. doi:10.1007/s11427-013-4577-y.
23. Cai X, Schafer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, et al. Epstein–Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2006;2(3):e23. doi:10.1371/journal.ppat.0020023.
24. Wu Y, Maruo S, Yajima M, Kanda T, Takada K. Epstein–Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation. J Virol. 2007;81(20):11236–45. doi:10.1128/JVI.00579-07.
25. Shi W, Pataki I, MacMillan C, Pintilie M, Payne D, O’Sullivan B, et al. Molecular pathology parameters in human nasopharyngeal carcinoma. Cancer. 2002;94(7):1997–2006.
26. Cayrol C, Flemington E. G0/G1 growth arrest mediated by a region encompassing the basic leucine zipper (bZIP) domain of the Epstein–Barr virus transactivator Zta. J Biol Chem. 1996;271(50):31799–802.
27. Cayrol C, Flemington EK. The Epstein–Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 1996;15(11):2748–59.
28. Guo Q, Sun X, Yuan C, Zhou H, Li Y, Jie G, et al. Effect of Rta protein of Epstein–Barr virus on the cell cycle in HeLa cells. Acta Virol. 2011;55(4):311–6.
29. Huang SY, Hsieh MJ, Chen CY, Chen YJ, Chen JY, Chen MR, et al. Epstein–Barr virus Rta-mediated transactivation of p21 and 14-3-3sigma arrests cells at the G1/S transition by reducing cyclin E/CDK2 activity. J gen Virol. 2012;93(Pt 1):139–49. doi:10.1099/vir.0.034405-0.
30. Choi H, Lee H, Kim SR, Gho YS, Lee SK. Epstein–Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. J Virol. 2013;87(14):8135–44. doi:10.1128/JVI.03159-12.
31. Samanta M, Iwakiri D, Kanda T, Imaizumi T, Takada K. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 2006;25(18):4207–14. doi:10.1038/sj.emboj.7601314.
32. Ambinder RF. Gammaherpesviruses and “Hit-and-Run” oncogenesis. Am J Pathol. 2000;156(1):1–3. doi:10.1016/S0002-9440(10)64697-4.
33. Niller HH, Wolf H, Minarovits J. Viral hit and run-oncogenesis: genetic and epigenetic scenarios. Cancer Lett. 2011;305(2):200–17. doi:10.1016/j.canlet.2010.08.007.
34. Samanta M, Takada K. Modulation of innate immunity system by Epstein–Barr virus-encoded non-coding RNA and oncogenesis. Cancer Sci. 2010;101(1):29–35. doi:10.1111/j.1349-7006.2009.01377.x.
35. Gong Z, Zhang S, Zhang W, Huang H, Li Q, Deng H, et al. Long non-coding RNAs in cancer. Sci China Life sci. 2012;55(12):1120–4. doi:10.1007/s11427-012-4413-9.
36. Tang K, Wei F, Bo H, Huang HB, Zhang WL, Gong ZJ, et al. Cloning and functional characterization of a novel long non-coding RNA gene associated with hepatocellular carcinoma. Prog Biochem Biophys. 2014;41(2):153–62. doi:10.3724/Sp.J.1206.2012.00613.
37. Gong Z, Zhang S, Zeng Z, Wu H, Yang Q, Xiong F, et al. LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2. PLoS One. 2014;9(11):e110674. doi:10.1371/journal.pone.0110674.
38. Zhang W, Huang C, Gong Z, Zhao Y, Tang K, Li X, et al. Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma. J Mol Histol. 2013;44(5):545–54. doi:10.1007/s10735-013-9503-x.